Rankings
▼
Calendar
TMDX Q3 2025 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena
TMDX
TransMedics Group, Inc.
$5B
Q3 2025 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$144M
+32.2% YoY
Gross Profit
$85M
58.8% margin
Operating Income
$23M
16.2% margin
Net Income
$24M
16.9% margin
EPS (Diluted)
$0.66
QoQ Revenue Growth
-8.6%
Cash Flow
Operating Cash Flow
$70M
Free Cash Flow
$62M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$946M
Total Liabilities
$591M
Stockholders' Equity
$355M
Cash & Equivalents
$466M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$144M
$109M
+32.2%
Gross Profit
$85M
$61M
+39.0%
Operating Income
$23M
$4M
+493.9%
Net Income
$24M
$4M
+476.8%
Revenue Segments
Product
$88M
61%
Service
$56M
39%
← FY 2025
All Quarters
Q4 2025 →